[To what extent Africa can limit the impact of the COVID-19 pandemic?]
Jusqu’où l’Afrique peut-elle limiter l’impact de la pandémie de COVID-19 ?
Africa
/ epidemiology
BCG Vaccine
/ therapeutic use
Betacoronavirus
/ physiology
COVID-19
Climate
Coronavirus Infections
/ economics
Health Resources
/ organization & administration
History, 20th Century
History, 21st Century
Humans
Infection Control
/ economics
Pandemics
/ economics
Pneumonia, Viral
/ economics
Poverty Areas
Professional Role
Public Health
/ economics
SARS-CoV-2
Social Media
Social Responsibility
Socioeconomic Factors
World Health Organization
Africa
Afrique
COVID-19
Facteurs de propagation
Propagation factors
Journal
Revue d'epidemiologie et de sante publique
ISSN: 0398-7620
Titre abrégé: Rev Epidemiol Sante Publique
Pays: France
ID NLM: 7608039
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
07
06
2020
revised:
14
08
2020
accepted:
19
08
2020
pubmed:
20
9
2020
medline:
8
10
2020
entrez:
19
9
2020
Statut:
ppublish
Résumé
Following the onset of the global COVID-19 pandemic and the alerts issued by the World Health Organization, for several months attention has been focused on Africa as a potentially severely endangered continent. A sizable number of African countries, mainly low and middle income, suffer from limited available resources, especially in critical care, and COVID-19 is liable to overwhelm their already fragile health systems. To effectively manage what is shaping up as a multidimensional crisis, the challenge unquestionably goes beyond the necessary upgrading of public health infrastructures. It is also a matter of anticipating and taking timely action with regard to factors that may mitigate the propagation of SARS-CoV2 and thereby cushion the shock of the pandemic on the African continent. While some of these factors are largely unmanageable (climate, geography…), several others (socio-cultural, religious, audio-visual, and potentially political…) could be more or less effectively dealt with by African governments and populations.
Identifiants
pubmed: 32948360
pii: S0398-7620(20)30434-X
doi: 10.1016/j.respe.2020.08.002
pmc: PMC7480264
pii:
doi:
Substances chimiques
BCG Vaccine
0
Types de publication
Historical Article
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
302-305Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.
Références
JAMA. 2020 Apr 28;323(16):1549-1550
pubmed: 32176764
Lancet. 2020 Aug 1;396(10247):295-298
pubmed: 32628904
Lancet. 2020 May 16;395(10236):1545-1546
pubmed: 32359402
Clin Infect Dis. 2020 Jul 28;71(15):875-878
pubmed: 32227121
J Glob Health. 2019 Dec;9(2):020409
pubmed: 31448113
JAMA Netw Open. 2020 Jun 1;3(6):e2011834
pubmed: 32525550
Lancet Glob Health. 2020 Jul;8(7):e884-e885
pubmed: 32416768
J Med Virol. 2020 Sep;92(9):1373-1375
pubmed: 32196700
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10905-10910
pubmed: 31085641
N Engl J Med. 2020 Jul 16;383(3):e11
pubmed: 32302075
J Clin Invest. 2020 Jun 1;130(6):2741-2744
pubmed: 32224550
Nat Med. 2020 Mar;26(3):310-311
pubmed: 31988464
Emerg Microbes Infect. 2020 Dec;9(1):1300-1308
pubmed: 32458760
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Lancet Glob Health. 2020 May;8(5):e631-e632
pubmed: 32246918
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451367